Antimicrobial Resistance and Infection Control is a global forum for reports encompassing all aspects of resistance development and prevention of health-care associated infections in all health-care settings Antimicrobial Resistance and Infection Control aims to be a global forum for all those working on the prevention, diagnostic and treatment of health-care associated infections and antimicrobial resistance development in all health-care settings. Infection Control wishes to cover a broad spectrum of 'preeminent practices' and 'best available data' to the 'best interventional and translational research' and innovative (technical) developments in the field of infection control.Antimicrobial Resistance and Infection Control believes that a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, possibilities to prevent transmission and infections and insight into the difference between developed countries and countries with limited resources are key-factors to find future solutions. Antimicrobial Resistance and Infection Control needs to combine best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. Antimicrobial Resistance and Infection Control welcomes all manuscripts related to the filed of HAI prevention and infection control. Some examples are listed below: Prevention of health-care associated infection in hospitals.Infection control and antimicrobial-resistance in high-risk settings (e.g. ICUs).HAI prevention and antimicrobial-resistance in special settings e.g. long-term care facilities.Infection control and antimicrobial-resistance in community settings.Special problems with Infection control and antimicrobial-resistance in resource-limited countries.
Human Psychopharmacology: Clinical and Experimental provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines. Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered. While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome. The following topics are of special interest to the editors and readers of the Journal:
Published since 1953, Psychotherapy and Psychosomatics has progressively increased its reputation for independence, originality, and methodological rigor. It has anticipated and developed new lines of research concerned with psychosomatic medicine, psychotherapy research, and psychopharmacology. Ranking among the world’s most cited journals in the field now, Psychotherapy and Psychosomatics provides a unique forum for current and controversial issues and innovations in assessment and treatment. As the official journal of the International College of Psychosomatic Medicine and the International Federation for Psychotherapy, it is the home of cutting-edge thinking at the interface between medical and behavioral sciences, addressed to both practicing clinicians and researchers.
The original papers published in the European Archives of Psychiatry and Clinical Neuroscience deal with all aspects of psychiatry and related clinical neuroscience.Clinical psychiatry, psychopathology, epidemiology as well as brain imaging, neuropathological, neurophysiological, neurochemical and moleculargenetic studies of psychiatric disorders are among the topics covered. Thus both the clinician and the neuroscientist are provided with a handy source of information on important scientific developments.Fields of interest: Psychiatry (psychopathology, clinical psychiatry, epidemiology, genetics), neurological sciences (neuropathology, neurophysiology, neurochemistry, neuropsychology, neurology, neurosurgery).
Academic Psychiatry publishes original scholarly work dedicated to innovative psychiatric education, professional development in academic psychiatry, and leadership by psychiatrists in the field of medicine. The journal aims to further knowledge in psychiatric education and stimulate improvements in the field of Academic Psychiatry. Articles address teaching, research, and administration, as well as clinical, organizational, and economic issues relevant to the academic missions of departments of psychiatry. Other features include a New Ideas section, commentaries and letters to the editor. Academic Psychiatry also gathers the best papers from meeting workshops, provides a forum for debate, and presents theme issues that focus on a single area of psychiatric education.
Acta Neuropsychiatrica is an international journal that publishes high-quality research papers in neuropharmacology neuropsychiatry and neuroscience. The journal provides a forum for original basic and clinical research from disciplines and research areas relevant to the pathophysiology, neurobiology, and treatment of neuropsychiatric disorders. Acta Neuropsychiatrica provides its readership with the latest perspectives from current and emerging fields of psychiatry, neurology, pharmacology, genetics and neuroimaging. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques/strategies. Emphasis will be given to original research that is of wide interest and clearly advances the field.
Addictive Disorders & Their Treatment is a quarterly, international journal devoted to practical clinical research and treatment issues related to the misuse of alcohol, licit and illicit drugs, and the study and treatment of addictive disorders and their behaviors. Original articles help clinicians make more educated, effective decisions regarding optimal patient management and care. In-depth reviews examine current understanding, diagnosis, and treatment of addiction disorders. Short reports include preliminary communications or case reports on unusual or otherwise important aspects of addiction disorders. Case reviews provide comprehensive case presentations emphasizing key points in the differential diagnosis, workup, and treatment plan. Special sections include editorials, book reviews, meeting announcements, and letters to the editor. For more information, visit www.addictiondisorders.com.
Peer Review Policy: All articles in this journal have undergone rigorous anonymous double-blind peer review, based on initial editor screening and anonymous refereeing by two anonymous referees.
Complex Psychiatry is a peer-reviewed, rapid communication journal that focuses on the complexity of psychiatry and human behavior considering a wide range of methods – including genomics, epigenomics, transcriptomics, proteomics, metabolomics, pharmacogenomics, bioinformatics, molecular neuropharmacology, neural circuits, neural stem cells, and systems neurobiology in humans, and in animal and cellular model systems. The journal publishes original research articles and reviews that shed light onto the biology of psychiatric illness and complex behavioral traits. Submitted papers will be subject to an editorial review, and a decision whether to further peer review will be made in approximately 5 business days. We aim to have an initial review decision within 1 month. Simultaneous BioRxiv submission is strongly encouraged.
The journal provides a forum for clinicians and investigators of markedly divergent concepts, methods and orientations. Clear, concise reports cover developments in clinical and basic investigations as well as new diagnostic and therapeutic practices. Comprehensive Psychiatry is of interest to psychiatrists, psychotherapists and clinical psychologists.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Contemporary Psychoanalysis, a double blind peer-reviewed international quarterly, is the journal of the William Alanson White Institute and the William Alanson White Psychoanalytic Society. We publish creative and original psychoanalytic writing from both new and experienced authors. Although we very much encourage diverse perspectives, our primary focus is on interpersonal and relational psychoanalysis. Our pages include a mix of the scholarly and the clinical, the heady and the playful. We are committed to providing authors with thoughtful reviews and working one-on-one with them to craft articles that contribute substantively to the literature.
Publication office: Taylor & Francis, Inc., 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
clinical application, or which provides insights into the biological basis of neuropsychiatric disorders and thereby advances their pharmacological treatment. Such research might derive from the full spectrum of biological and psychological fields of inquiry, encompassing classical and novel techniques in neuropsychopharmacology, as well as strategies such as neuroimaging, genetics, psycho-neuroendocrinology and neuropsychology. IJNP's rapid publication policy is facilitated by web-based submission and review, and the journal publishes the definitive versions of papers online, ahead of the printed issues. All papers are indexed in PubMed and Thomson Reuters Journal Citation Reports.
The Journal of LGBT Issues in Counseling provides a professional forum for research, best practices, and emerging trends and issues relating to counseling the GLBT community. Rather than narrowing the focus on a particular approach for treatment or a specific topic, this journal encompasses all aspects of LGBT counseling for youth as well as adults with attention to the prevention of problems and the fulfillment of human potential at all stages of life. Peer Review Policy: All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous refereeing by three anonymous referees. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower. Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery.
The Journal of Abnormal Child Psychology brings together the latest research on psychopathology in childhood and adolescence, with an emphasis on empirical studies of the major childhood disorders (the disruptive behavior disorders, depression, anxiety, and pervasive developmental disorders). Studies focus on the epidemiology, etiology, assessment, treatment, prognosis, follow-up, and developmental course of child and adolescent disorders. Studies highlighting risk and protective factors, the ecology and correlates of children's behavior problems, and advances in prevention and treatment are featured. The Journal of Abnormal Child Psychology is the official journal of the International Society for Research in Child and Adolescent Psychopathology (ISRCAP), a multidisciplinary scientific society.